Literature DB >> 18774496

Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma.

Rahayu Md Zin Reena1, Mokhtar Mastura, Md Ali Siti-Aishah, Md Ali Munirah, Abdullah Norlia, Ibrahim Naqiyah, Muhamad Rohaizak, Noor Akmal Sharifah.   

Abstract

This is a study aimed to examine the distribution pattern of a specific minichromosome maintenance protein 2 (MCM2) in benign and malignant breast tissue. We also aim to correlate the frequency of expression of MCM2 with the degree of tumor differentiation. We used immunohistochemistry to examine the distribution and expression pattern of MCM2 on formalin-fixed paraffin-embedded tissue sections of benign (n = 30) and malignant breast tissue (n = 70) (IDC 56, DCIS 4, ILC 2, nonductal 4, mixed type 4). We quantified MCM2 expression by calculating a labeling index, which represents the percentage of epithelial nuclei that stained positively. Immunoreactivity was heterogenous in all the 70 malignant cases examined. Epithelial cells in cycle are most frequent at the tumor periphery. Labeling index of MCM2 was greatest in grade 3 (poorly differentiated) and lowest in grade 1 tumors (well differentiated). Minichromosome maintenance protein 2 expression in breast cancer showed a positive association with histologic grade (P < .05). In all the benign breast tissue examined, no proliferating compartments could be characterized. Minichromosome maintenance protein 2 is a useful proliferative marker of breast carcinoma. The frequency of expression of MCM2 showed an inverse correlation with the degree of tumor differentiation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774496     DOI: 10.1016/j.anndiagpath.2008.04.001

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  7 in total

1.  MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation.

Authors:  Einas M Yousef; Daniela Furrer; David L Laperriere; Muhammad R Tahir; Sylvie Mader; Caroline Diorio; Louis A Gaboury
Journal:  Mod Pathol       Date:  2017-01-13       Impact factor: 7.842

2.  Breast cancer biomarker discovery in the functional genomic age: a systematic review of 42 gene expression signatures.

Authors:  M C Abba; E Lacunza; M Butti; C M Aldaz
Journal:  Biomark Insights       Date:  2010-10-27

3.  Lithium chloride treatment induces epithelial cell proliferation in xenografted human endometrium.

Authors:  Alex J Polotsky; Liyin Zhu; Nanette Santoro; Jeffrey W Pollard
Journal:  Hum Reprod       Date:  2009-04-29       Impact factor: 6.918

4.  Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a.

Authors:  F Liu; J-H Yuan; J-F Huang; F Yang; T-T Wang; J-Z Ma; L Zhang; C-C Zhou; F Wang; J Yu; W-P Zhou; S-H Sun
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

5.  Novel molecular markers of malignancy in histologically normal and benign breast.

Authors:  Aejaz Nasir; Dung-Tsa Chen; Mike Gruidl; Evita B Henderson-Jackson; Chinnambally Venkataramu; Susan M McCarthy; Heyoung L McBride; Eleanor Harris; Nazanin Khakpour; Timothy J Yeatman
Journal:  Patholog Res Int       Date:  2011-07-10

6.  MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder.

Authors:  Ziru Liu; Zhulin Yang; Song Jiang; Qiong Zou; Yuan Yuan; Jinghe Li; Daiqiang Li; Lufeng Liang; Meigui Chen; Senlin Chen
Journal:  Mol Med Rep       Date:  2016-10-13       Impact factor: 2.952

7.  Hippocampal proliferation is increased in presymptomatic Parkinson's disease and due to microglia.

Authors:  Karlijn J Doorn; Benjamin Drukarch; Anne-Marie van Dam; Paul J Lucassen
Journal:  Neural Plast       Date:  2014-08-14       Impact factor: 3.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.